ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
1H, 15N, 13C Resonance Assignments of the Reduced and Active Form of Human Protein Tyrosine Phosphatase, PRL-1
dc.contributor.author | Skinner, Andria L. | |
dc.contributor.author | Laurence, Jennifer S. | |
dc.date.accessioned | 2017-04-28T20:36:45Z | |
dc.date.available | 2017-04-28T20:36:45Z | |
dc.date.issued | 2009-06 | |
dc.identifier.citation | Skinner, A. L., & Laurence, J. S. (2009). 1H, 15N, 13C Resonance Assignments of the Reduced and Active Form of Human Protein Tyrosine Phosphatase, PRL-1. Biomolecular NMR Assignments, 3(1), 61–65. http://doi.org/10.1007/s12104-008-9142-4 | en_US |
dc.identifier.uri | http://hdl.handle.net/1808/23860 | |
dc.description.abstract | Phosphatase of regenerating liver-1 (PRL-1) is a novel target for potentially treating cancer metastases. Although its specific biochemical role in these processes has yet to be delineated, considerable evidence suggests the phosphatase activity of PRL-1 is required for promoting cancer and metastasis. PRL-1 belongs to the protein tyrosine phosphatase (PTPase) family and functions using the CX5R consensus active site motif. Like other PTPases, PRL-1 is inhibited by oxidation at its active site Cys, however, disulfide bond formation occurs unusually readily in wild-type PRL-1. Chemical shift assignments are available for oxidized wild type, but numerous, substantial changes are observed in the spectra upon reduction. Because the reduced form is active, we sought to identify a stable mutant that would resist oxidation and be useful for facilitating drug screening and development using NMR-based assays. We present here NMR assignments for a full-length, reduced and active form of PRL-1, PRL-1-C170S-C171S, that is well suited for this purpose. | en_US |
dc.publisher | Springer Verlag | en_US |
dc.rights | © Springer Science+Business Media B.V. 2009 | en_US |
dc.title | 1H, 15N, 13C Resonance Assignments of the Reduced and Active Form of Human Protein Tyrosine Phosphatase, PRL-1 | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Skinner, Andria L. | |
kusw.kuauthor | Laurence, Jennifer S. | |
kusw.kudepartment | Pharmaceutical Chemistry | en_US |
dc.identifier.doi | 10.1007/s12104-008-9142-4 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC2719816 | en_US |
dc.rights.accessrights | openAccess |